Personalis is helping Pharma drive the development of next generation cancer immunotherapies through a deeper understanding of neoantigens, tumor escape mechanisms, and the tumor microenvironment.
ACE ImmunoID Neoantigen Detection
for Personalized Cancer Detection
ACE CancerPlus Test
Comprehensive Genomic Tumor Profiling
ACE ImmunoID Mutational Assessment
for Immune Modulators
Select a gene from the dropdown list on the right to see the difference between a standard exome coverage vs. coverage with the ACE Exome.